| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Emily M Eshleman, PHD | Epithelial antigen presentatio | National Institutes of Health (NIH) | F32AI147591 | 4/1/22-3/31/23 | $1,272 | 
        
            | Ian P Lewkowich | Elucidating the mechanisim of | National Institutes of Health (NIH)/University of Cincinnati | 011429-00080 | 4/1/21-3/31/22 | $10,000 | 
        
            | David A Hildeman, PHD | Regulation of C. difficile colitis by host genetic | National Institutes of Health (NIH)/University of Cincinnati | 013939-00002 | 9/17/21-8/31/22 | $10,122 | 
        
            | Senad Divanovic, PHD | Fibrin(ogen) control of metabolic inflammation and | National Institutes of Health (NIH)/University of North Carolina | 5116413 | 12/1/21-11/30/22 | $14,531 | 
        
            | David A Hildeman, PHD | Obtain healthy reference tissu | National Institutes of Health (NIH)/University of Cincinnati | 012507-002 | 9/1/19-6/30/21 | $20,165 | 
        
            | Harry Leighton Grimes, PHD | Defining human hematopoietic cells via transcriptomes an | National Institutes of Health (NIH) | 1R21HL150678-01 | 1/1/21-12/31/21 | $26,649 | 
        
            | Harry Leighton Grimes, PHD | Mechanisms whereby IFN-gamma sensitizes AML to the | National Institutes of Health (NIH)/University of Pittsburgh | AWD00003978 | 4/20/21-3/31/22 | $35,168 | 
        
            | Theresa Alenghat | Microbiota-sensitive epigenetic regulation of IBD | Kenneth Rainin Foundation | KRF_Alenghat | 4/1/22-3/31/23 | $50,000 | 
        
            | Michael B Jordan, MD | Harnessing insights from immun | Cancer Free Kids | CFK_Jordan | 7/1/21-6/30/22 | $50,000 | 
        
            | Maria Eugenia Fields, PHD | Pathogenic potential of Th17 a | American Diabetes Association | ADA Fields - Divanov | 7/1/21-6/30/22 | $65,645 | 
        
            | Senad Divanovic, PHD | Immunopathogenesis of non-alcoholic fatty liver di | National Institutes of Health (NIH) | R01DK099222 | 8/1/21-7/31/22 | $67,836 | 
        
            | Claire A Chougnet, PHD | Mechanistic and therapeutic ro | National Institutes of Health (NIH)/University of California-Davis | cfda 93.847 | 6/1/20-5/31/21 | $70,720 | 
        
            | Theresa Alenghat | Dietary regulation of innate intestinal immunity | Burroughs Wellcome Foundation/University of Cincinnati | BWF_Alenghat | 7/1/21-6/30/22 | $100,000 | 
        
            | Claire A Chougnet, PHD | Discovery of Molecular Targets | National Institutes of Health (NIH)/UCLA School of Public Health | R01HD098389 | 4/1/21-3/31/22 | $103,488 | 
        
            | Andrew Herr, PHD | Rapid, safe suppression of IgE | National Institutes of Health (NIH)/University of Cincinnati | 012329-003 | 7/1/21-6/30/22 | $112,783 | 
        
            | Andrew Herr, PHD | Mechanisms of staphylococcal skin colonization - Resubmi | National Institutes of Health (NIH)/University of Nebraska Medical Center | 34-5301-2207-201 | 9/15/21-8/31/22 | $206,972 | 
        
            | Michael B Jordan, MD | Redefining hemophagocytic lymphohistiocytosis in h | National Institutes of Health (NIH) | R21CA256390 | 12/1/21-11/30/22 | $218,538 | 
        
            | Chandrashekhar Pasare DVM | (PQ10) Role of Gut Microbiota | National Institutes of Health (NIH)/The University of Texas Southwestern | PO: 000001910A GMO 2 | 9/1/21-8/31/22 | $221,363 | 
        
            | Artem Barski, PHD | An experimentally-refined, dyn | National Institutes of Health (NIH) | RAI153442B | 3/1/22-2/28/23 | $351,914 | 
        
            | Harry Leighton Grimes, PHD | Regulation of functionally discrete hematopietic s | National Institutes of Health (NIH) | R01DK121062 | 1/1/22-12/31/22 | $260,848 | 
        
            | David A Hildeman, PHD | Proteasome targeting for alloreactive plasma cells | National Institutes of Health (NIH)/University of Pennsylvania | 580121 | 7/1/21-6/30/22 | $310,102 | 
        
            | Claire A Chougnet, PHD | Regulation and function of immune suppressive T ce | National Institutes of Health (NIH) | 1R56AG065327-01A1 | 9/1/21-8/31/22 | $325,950 | 
        
            | Andrew Herr, PHD | Studies of Metal-Dependent Intercellular Adhesion in Staphylococcal Biofilms | National Institutes of Health (NIH) | 2R01GM094363-06A1 | 7/1/21-6/30/23 | $339,112 | 
        
            | Theresa Alenghat | Epigenomic control of antimicrobial immunity in the intestine | National Institutes of Health (NIH) | R01DK114123 | 5/1/22-4/30/23 | $357,887 | 
        
            | Emily R Miraldi, PHD | Dynamic regulatory network models of human respons | National Institutes of Health (NIH)/Icahn School of Medicine at Mount Sinai | 0255-E053-4609 | 6/1/21-5/31/22 | $398,294 | 
        
            | Ian P Lewkowich | Perinatal Dysbiosis, Lung Development and Asthma | National Institutes of Health (NIH) | R01HL149366 | 6/1/22-5/31/23 | $398,560 | 
        
            | Ian P Lewkowich | Preconceptual paternal allergen exposure, offsprin | National Institutes of Health (NIH) | 1R21AI156185-01A1 | 6/1/22-5/31/23 | $437,250 | 
        
            | Jonathan D Katz, PHD | Manipulating DNA Damage-respon | National Institutes of Health (NIH) | R01DK117632 | 1/1/22-12/31/22 | $446,790 | 
        
            | Chandrashekhar Pasare DVM | Innate mechanisms of regulatio | National Institutes of Health (NIH) | R01AI123176 | 1/4/22-12/31/22 | $477,000 | 
        
            | Senad Divanovic, PHD | Immunopathogenesis of non-alcoholic fatty liver disease | National Institutes of Health (NIH) | R01DK099222 | 8/1/21-7/31/22 | $554,436 | 
        
            | Senad Divanovic, PHD | Inflammatory vigor in heteroge | Department of Defense Army | W81XWH2010392 | 7/1/21-6/30/22 | $577,143 | 
        
            | Harry Leighton Grimes, PHD | Modeling myelodysplasia | National Institutes of Health (NIH) | R01CA253981 | 1/1/22-12/31/22 | $592,469 | 
        
            | Tamara Tilburgs, PHD | THE ROLE OF HLA-G /C  EXTRAVILLOUS TROPHOBLASTS IN | Burroughs Wellcome Foundation/University of Cincinnati | FWA 00002988 | 6/1/21-3/31/22 | $667,501 | 
        
            | Claire A Chougnet, PHD | Prenatal inflammatory exposures and neonatal immune deve | National Institutes of Health (NIH) | U01ES029234 | 9/1/21-8/31/22 | $800,299 | 
        
            | Michael B Jordan, MD | Abatacept for the treatment of | Food and Drug Administration | 1R01FD007267-01 | 9/10/21-6/30/22 | $815,329 | 
        
            | Chandrashekhar Pasare DVM | Regulation of TLR signaling, Inflammation and Anti | National Institutes of Health (NIH) | 1R01AI155426-01A1 | 7/1/21-6/30/22 | $964,613 | 
        
            | Total Annual Grant Award Dollars | $10,460,749 |